Search - tctmd.com

Displaying 1 - 20 of 83

Sort: Relevancy | Date

News Daily News

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

L.A. McKeown

January 16, 2025

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Yael L. Maxwell

April 03, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

Aortic Disease Deaths Tied to Modifiable Risk Factors, Japanese Data Confirm

Caitlin E. Cox

April 18, 2023

News Daily News

MR CLEAN-LATE Affirms 24-Hour Window Safe for Endovascular Stroke Therapy

Yael L. Maxwell

April 07, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

‘It’s All Cuts’: Cardiologists React to the 2023 CMS Proposed Rule

Yael L. Maxwell

July 15, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Medtronic Recalls TurboHawk Plus Atherectomy System

Todd Neale

March 09, 2022

Advertisement

Lost Chances: Medicare Analysis Says Preamputation Vascular Care Eludes Many

Scientific Statement Reviews Current Antithrombotic Options in PAD

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Physicians (Mostly) Negative on Private Equity in Healthcare

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

Aortic Disease Deaths Tied to Modifiable Risk Factors, Japanese Data Confirm

MR CLEAN-LATE Affirms 24-Hour Window Safe for Endovascular Stroke Therapy

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

‘It’s All Cuts’: Cardiologists React to the 2023 CMS Proposed Rule

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Medtronic Recalls TurboHawk Plus Atherectomy System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content